文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

成人复杂性嗜酸性食管炎的表型以诊断延迟延长5年为主:基于丹麦嗜酸性食管炎队列的人群研究。

The phenotype of adults with complicated eosinophilic esophagitis is dominated by a 5-year longer diagnostic delay: A population-based study of the DanEoE cohort.

作者信息

Henriksen Stine D, Hansen Stine K, Heinesen Mia, Terkelsen Jacob H, Hollænder Martin, Bredal Kasper, Melgaard Dorte, Krarup Anne L

机构信息

Department of Gastrointestinal Surgery Aalborg University Hospital Aalborg Denmark.

Department of Clinical Medicine Aalborg University Aalborg Denmark.

出版信息

JGH Open. 2023 Aug 17;7(8):553-558. doi: 10.1002/jgh3.12947. eCollection 2023 Aug.


DOI:10.1002/jgh3.12947
PMID:37649863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10463020/
Abstract

BACKGROUND AND AIM: The DanEoE is a previously described population- and register-based cohort of 236 adult patients with eosinophilic esophagitis (EoE) in a well-defined Danish region with a population of 580 000 and free medical treatment. The aim of the study was to compare the phenotype and treatment response between EoE patients with complications to patients without complications at diagnosis. METHODS: A retrospective cross-sectional study of the DanEoE cohort's 236 adult EoE patients diagnosed between 2007 and 2017 in the North Denmark Region. Patients were divided into a group who had had complications (dilated or food bolus obstruction [FBO]) before or at the diagnosis, and a group without. RESULTS: At the diagnostic endoscopy, 61% had never had a complication, and 39% had either had FBO ( = 77) or been dilated ( = 15). The complicated group had the same mean age at symptom debut (37 [SD = 16] 37 [SD = 17] years,  = 1.0), but were diagnosed significantly later with a resulting longer diagnostic delay (13 [SD = 13] 7.9 [SD = 11] years,  = 0.01). Almost half of all patients were never treated to symptomatic remission (uncomplicated 40%, complicated 49%). The histological remission was not secured in the majority (uncomplicated 68%, complicated 70%). Despite this, <15% of patients with previous FBO experienced this after the diagnosis. CONCLUSION: In the population-based DanEoE cohort, results indicated that the complicated EoE phenotype was a patient with a 5-year longer diagnostic delay. In the current study, the complication status did not predict the treatment response.

摘要

背景与目的:丹麦嗜酸性食管炎(DanEoE)是此前所描述的一个基于人群和登记系统的队列,由丹麦一个明确划定的地区的236例成年嗜酸性食管炎(EoE)患者组成,该地区人口为58万,且提供免费医疗。本研究的目的是比较诊断时伴有并发症的EoE患者与无并发症患者的表型和治疗反应。 方法:对2007年至2017年在丹麦北部地区诊断的DanEoE队列中的236例成年EoE患者进行回顾性横断面研究。患者被分为在诊断前或诊断时出现并发症(扩张或食物团块梗阻[FBO])的组和无并发症的组。 结果:在诊断性内镜检查时,61%的患者从未出现过并发症,39%的患者曾出现FBO(n = 77)或接受过扩张治疗(n = 15)。并发症组在症状首次出现时的平均年龄相同(37[标准差=16]对37[标准差=17]岁,P = 1.0),但诊断明显更晚,导致诊断延迟更长(13[标准差=13]对7.9[标准差=11]年,P = 0.01)。几乎一半的患者从未接受治疗至症状缓解(无并发症组为40%,并发症组为49%)。大多数患者未实现组织学缓解(无并发症组为68%,并发症组为70%)。尽管如此,既往有FBO的患者中<15%在诊断后仍经历过FBO。 结论:在基于人群的DanEoE队列中,结果表明,伴有并发症的EoE表型患者诊断延迟长5年。在本研究中,并发症状态不能预测治疗反应。

相似文献

[1]
The phenotype of adults with complicated eosinophilic esophagitis is dominated by a 5-year longer diagnostic delay: A population-based study of the DanEoE cohort.

JGH Open. 2023-8-17

[2]
A diagnostic delay of 10 years in the DanEoE cohort calls for focus on education - a population-based cross-sectional study of incidence, diagnostic process and complications of eosinophilic oesophagitis in the North Denmark Region.

United European Gastroenterol J. 2021-7

[3]
An improved guideline adherence and PPI efficacy has been accompanied by a decrease in diagnostic delay, and strictures before diagnosis of eosinophilic esophagitis in the North Denmark Region - a retrospective registry study of the DanEoE cohorts.

Clin Res Hepatol Gastroenterol. 2023-8

[4]
Are patients with eosinophilic esophagitis treated at an academic hospital comparable to a patient from a population-based cohort? Not in Denmark.

JGH Open. 2023-8-17

[5]
Effectiveness of treatment with budesonide orodispersible tablets in 76 patients with eosinophilic oesophagitis - real-life experience from the population-based DanEoE cohort.

Scand J Gastroenterol. 2024-10

[6]
Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis-Results from the population-based DanEoE cohort shows a low complication rate.

United European Gastroenterol J. 2021-10

[7]
A retrospective cohort study on oesophageal food bolus obstruction in the North Denmark region in 2021-two thirds were never diagnosed with a cause.

BMC Gastroenterol. 2024-1-2

[8]
The incidence of eosinophilic oesophagitis in 2007-2017 among children in North Denmark Region is lower than expected.

BMC Pediatr. 2022-4-6

[9]
No gender differences in patients with eosinophilic oesophagitis.

Dan Med J. 2023-1-17

[10]
There is a long way from current clinical practice in Denmark compared to recent published English guideline on management of children with eosinophilic oesophagitis.

BMC Pediatr. 2024-1-8

引用本文的文献

[1]
Systematic Review: Variability in Definitions of Fibrostenosis in Eosinophilic Oesophagitis.

Aliment Pharmacol Ther. 2025-8

[2]
Epidemiology of Eosinophilic Esophagitis: Really a Novel and Evolving Disease?

Inflamm Intest Dis. 2025-1-20

本文引用的文献

[1]
British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults.

Gut. 2022-8

[2]
A diagnostic delay of 10 years in the DanEoE cohort calls for focus on education - a population-based cross-sectional study of incidence, diagnostic process and complications of eosinophilic oesophagitis in the North Denmark Region.

United European Gastroenterol J. 2021-7

[3]
Implementation of a biopsy protocol to improve detection of esophageal eosinophilia: a Danish registry-based study.

Endoscopy. 2021-1

[4]
Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry.

Aliment Pharmacol Ther. 2020-7-17

[5]
Systematic review with meta-analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies.

Aliment Pharmacol Ther. 2019-3-18

[6]
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.

Gastroenterology. 2018-9-6

[7]
Natural history of eosinophilic esophagitis: a systematic review of epidemiology and disease course.

Dis Esophagus. 2018-8-1

[8]
Determinant factors of quality of life in adult patients with eosinophilic esophagitis.

United European Gastroenterol J. 2018-2

[9]
Rising incidence and prevalence of adult eosinophilic esophagitis in midwestern Spain (2007-2016).

United European Gastroenterol J. 2018-2

[10]
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.

Lancet. 2017-10-16

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索